Authors
Latest:
Verina on Tackling Neurological Toxicities From CAR T-Cell TherapyDaniel J. Verina, DNP, RN, MSN, ACNP-BC, underscores how nurses can assess neurological toxicities in both the inpatient and outpatient setting.
Latest:
Forgoing Select Lymph Node Dissection Linked With Superior Outcomes in Early-Stage Breast CancerUpdates from the ongoing INSEMA trial suggest that patients with early-stage breast cancer maintain superior quality of life by forgoing sentinel lymph node biopsy and axillary lymph node dissection.
Latest:
Supporting the Novice Oncology NP: The Benefits of PreceptorshipStructured preceptorships promote competence, confidence, and job satisfaction in new oncology nurse practitioners.
Latest:
Immediate Interventions to Support The Newly BereavedWhen engaging with a family member of a patient who has died, nurses should consider using immediate interventions aimed at supporting the loved ones who are in shock and in pain following their loss.
Latest:
Jennifer Cargile on Managing Cancer-Related Cognitive ImpairmentJennifer Cargile, MEd, CCC-SLP, shares some examples of how she helped patients continue their daily activities while they experienced symptoms of cancer-related cognitive impairment.
Latest:
FDA Approves Zanidatamab for Pretreated HER2-Positive Biliary Tract CancerThe FDA granted an accelerated approval to zanidatamab-hrii for previously treated, unresectable or metastatic HER2-positve biliary tract cancer.
Latest:
Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric CancerShared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
Latest:
Oncology Therapy at the End of Life: Have We Missed the Mark?"Over the last decade, the landscape of systemic anti-cancer therapy has changed dramatically following the approvals of multiple new targeted therapies," - Kerin Adelson, MD.
Latest:
Oncology Drug Crash Course: Elacestrant (Orserdu)Kristine Gibbons, RN, OCN, who is a Nurse Trainer at Florida Cancer Specialists & Research Institute, provides an in-depth look at elacestrant in a downloadable fact sheet.
Latest:
Charina Toste Discusses the Educational Obstacles Patients With MPNs FaceAccording to Charina Toste, DNP, APRN-C, AOCNP, MSN, BSN, RN, patients with newly diagnosed myeloproliferative neoplasms may be unaware of the questions they should be asking their providers.
Latest:
Advanced Practice Providers May Hold the Key to Improving Community Clinical Trial InvolvementSeventy-three percent of advanced practice providers reported that they are interested in becoming more involved with clinical trials.
Latest:
Expert Talks Significance of Relatlimab/Nivolumab Approval for Metastatic MelanomaHussein A. Tawbi, MD, PhD, principal investigator of the phase 2/3 RELATIVITY-046 trial, highlights the importance of relatlimab/nivolumab’s recent FDA approval in melanoma.
Latest:
Is a Health Care Price Transparency Revolution at Hand?The Transparency in Coverage Final Rule requires health care payers to unveil all previously secret negotiated prices with in-network providers.
Latest:
Integrated Behavioral Health Vs Standard Practice: What’s The Difference?A licensed clinical health psychologist with Allegheny Health Network discusses fully integrated behavioral health programs and how their design alleviates potential barriers to care that patients may experience.
Latest:
Disease Progression May Be More Common in Lower-Risk MyelofibrosisMost patients with lower-risk myelofibrosis, over a 4-year period, experienced disease progression, as demonstrated by the prospective MOST study.
Latest:
Adding Nivolumab to Chemo Increases OS, PFS in Previously Untreated Advanced GI CancersOverall survival and progression-free survival improves with nivolumab plus chemotherapy compared with chemotherapy alone in the overall population and in patients with a PD-L1 CPS of 5 or greater.
Latest:
Galinsky Breaks Down Venetoclax Symptom Management in AMLIlene Galinsky, BSN, MSN, ANP-C, underscores effective symptom management strategies when prescribing venetoclax to patients with acute myeloid leukemia.
Latest:
Normalize Conversations Between Patients and Providers on the Financial Costs of CancerNearly half of patients with gynecologic cancer reported financial distress as a result of the high costs of cancer treatment, yet money is still not commonly discussed between patients and providers.
Latest:
Brenda Martone Highlights Nursing Considerations With Darolutamide in Prostate CancerBrenda Martone MSN, ANP-BC, AOCNP, discusses what nurses need to know about safely treating patients with darolutamide.
Latest:
Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)Jeanelle S. King, PA-C, provides an in-depth look at nivolumab-relatlimab in a downloadable reference sheet.
Latest:
Gretchen McNally Speaks to the Role of Oncology Nurses in the Opioid EpidemicGretchen McNally PhD, ANP-BC, AOCN, spotlights the value that naloxone training for oncology nurses and providers could have for patients who are at a high-risk of overdose.
Latest:
Finding the Small WinsThe winner of the 2024 Extraordinary Healer® award, Meaghan Mooney, BSN, RN, OCN, found a rewarding career caring for patients and their families, even after transitioning to a leadership role. Now, she uses her expertise to help children facing a parent's cancer diagnosis.
Latest:
Rx Road Map: Enfortumab Vedotin (Padcev)Srigowri Kota, MSN, BA, APRN, AGNP-C, AOCNP, provides an in-depth look at enfortumab vedotin for the treatment of patients with urothelial cancer in a downloadable reference sheet.
Latest:
Anthracyclines Boost Survival, Increases Hospital Time in AMLOlder adults with acute myeloid leukemia treated with anthracyclines tended to live longer, but also had more time spent in the hospital compared with those treated with HMAs.
Latest:
Leuprolide, OCPs Manage Abnormal Uterine Bleeding in Stem Cell TransplantPharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.
Latest:
Complex Cancer Cases: Veno-Occlusive Disease in a Pediatric Patient Receiving Nontransplant-Associated ChemotherapyVeno-occlusive disease or sinusoidal obstruction syndrome is commonly associated as a complication with transplant in pediatric patients but can also be seen with chemotherapy alone.
Latest:
Patients With Cancer May Need Help Changing Their Eating ApproachesCaitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Power of Palliative Care: How Oncology Nurses Can Increase ReferralsA nurse-driven palliative care referral intervention demonstrated preliminary success in increasing the number of patients who received this form of supportive care.
